Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload

Authors: Dhahri, WahibaCouët, JacquesRoussel, ÉliseDrolet, Marie-ClaudeArsenault, Marie
Abstract: Aims : Fenofibrate is a peroxisome proliferator-associated receptor alpha agonist (PPARα) used clinically for the management of dyslipidemia and is a myocardial fatty acid oxidation stimulator. It has also been shown to have cardiac anti-hypertrophic properties but the effects of fenofibrate on the development of eccentric LVH and ventricular function in chronic left ventricular (LV) volume overload (VO) are unknown. This study was therefore designed to explore the effects of fenofibrate treatment in a VO rat model caused by severe aortic valve regurgitation (AR) with a focus on cardiac remodeling and myocardial metabolism. Main methods : Male Wistar rats were divided in four groups (13–15 animals/group): Shams (S) treated with fenofibrate (F; 100 mg/kg/d PO) or not (C) and severe AR receiving or not fenofibrate. Treatment was started one week before surgery and the animals were sacrificed 9 weeks later. Key findings : AR rats developed severe LVH (increased LV weight) during the course of the protocol. Fenofibrate did not reduce LV weight. However, eccentric LV remodeling was strongly reduced by fenofibrate in AR animals. Fractional shortening was significantly less affected in ARF compared to ARC group. Fenofibrate also increased the myocardial enzymatic activity of enzymes associated with fatty acid oxidation while inhibiting glycolytic enzyme phosphofructokinase. Significance : Fenofibrate decreased LV eccentric remodeling associated with severe VO and helped maintain systolic function. Studies with a longer follow-up will be needed to assess the long-term effects of fenofibrate in chronic volume overload caused by aortic regurgitation.
Document Type: Article de recherche
Issue Date: 7 November 2012
Open Access Date: 14 November 2017
Document version: AM
Permalink: http://hdl.handle.net/20.500.11794/15825
This document was published in: Life Sciences, Vol. 92 (1), 26–34 (2013)
https://doi.org/10.1016/j.lfs.2012.10.022
Pergamon
Alternative version: 10.1016/j.lfs.2012.10.022
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
SizeFormat 
Dhahri et al. 2012 LS.pdf553.91 kBAdobe PDFView/Open
All documents in CorpusUL are protected by Copyright Act of Canada.